- Home
- CNVS vs CNTB Comparison
CNVS vs CNTB Comparison
Compare CNVS & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNVS
- CNTB
- Stock Information
- Founded
- CNVS 2000
- CNTB 2012
- Country
- CNVS United States
- CNTB United States
- Employees
- CNVS N/A
- CNTB N/A
- Industry
- CNVS Consumer Electronics/Video Chains
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- CNVS Consumer Discretionary
- CNTB Health Care
- Exchange
- CNVS Nasdaq
- CNTB Nasdaq
- Market Cap
- CNVS 102.4M
- CNTB 114.8M
- IPO Year
- CNVS 2003
- CNTB 2021
- Fundamental
- Price
- CNVS $3.40
- CNTB $1.57
- Analyst Decision
- CNVS Buy
- CNTB Strong Buy
- Analyst Count
- CNVS 1
- CNTB 2
- Target Price
- CNVS $10.00
- CNTB $7.50
- AVG Volume (30 Days)
- CNVS 475.9K
- CNTB 188.4K
- Earning Date
- CNVS 11-13-2025
- CNTB 09-05-2025
- Dividend Yield
- CNVS N/A
- CNTB N/A
- EPS Growth
- CNVS N/A
- CNTB N/A
- EPS
- CNVS 0.13
- CNTB N/A
- Revenue
- CNVS $80,173,000.00
- CNTB $1,965,000.00
- Revenue This Year
- CNVS $1.28
- CNTB N/A
- Revenue Next Year
- CNVS N/A
- CNTB N/A
- P/E Ratio
- CNVS $25.46
- CNTB N/A
- Revenue Growth
- CNVS 77.07
- CNTB N/A
- 52 Week Low
- CNVS $0.73
- CNTB $1.56
- 52 Week High
- CNVS $7.39
- CNTB $2.20
- Technical
- Relative Strength Index (RSI)
- CNVS 29.30
- CNTB 39.75
- Support Level
- CNVS $3.29
- CNTB $1.63
- Resistance Level
- CNVS $3.91
- CNTB $1.79
- Average True Range (ATR)
- CNVS 0.30
- CNTB 0.18
- MACD
- CNVS -0.11
- CNTB -0.04
- Stochastic Oscillator
- CNVS 5.14
- CNTB 0.39
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.